Literature DB >> 17142741

Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes.

Yi Liu1, Xiaoni Gao, Emi Masuda, Patricia B Redecha, Marissa C Blank, Luminita Pricop.   

Abstract

Receptors for IgG (FcgammaR) expressed in dendritic cells (DCs) influence the initiation of Ab-mediated immunity. Dynamic variations in FcgammaR expression allow DCs to adjust their capacity to capture Ab-opsonized Ag. The current paradigm predicts a progressive decline in FcgammaR-mediated phagocytic function upon DC maturation. Surprisingly, we find that expression of the phagocytic receptor FcgammaRIIa is preserved in immature and mature DCs at comparable levels with macrophages. Moreover, phagocytosis of antigenic peptides directed to FcgammaRIIa on DCs leads to dramatic increases in Ag cross-presentation and T cell activation. In immature DCs, high expression of inhibitory FcgammaRIIb correlates with decreased uptake and cross-presentation of Ab-Ag complexes. In contrast, engagement of FcgammaRIIb is not associated with changes in cross-presentation in mature DCs. We provide evidence that FcgammaRIIb expression is patently reduced in mature DCs, an effect that is modulated by treatment with cytokines. The regulated expression of activating and inhibitory FcgammaRs in DCs emerges as a critical checkpoint in the process of Ag uptake and cross-presentation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142741     DOI: 10.4049/jimmunol.177.12.8440

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

Authors:  Richard A Hopkins; John E Connolly
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

2.  Dependence of surface monoclonal antibody binding on dynamic changes in FcgammaRIIb expression.

Authors:  Jennifer A Walker; Kenneth G C Smith
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

3.  Activation outcomes induced in naïve CD8 T-cells by macrophages primed via "phagocytic" and nonphagocytic pathways.

Authors:  Isabel María Olazabal; Noa Beatriz Martín-Cofreces; María Mittelbrunn; Gloria Martínez del Hoyo; Balbino Alarcón; Francisco Sánchez-Madrid
Journal:  Mol Biol Cell       Date:  2007-12-12       Impact factor: 4.138

4.  Dependence of antibody-mediated presentation of antigen on FcRn.

Authors:  Shuo-Wang Qiao; Kanna Kobayashi; Finn-Eirik Johansen; Ludvig M Sollid; Jan Terje Andersen; Edgar Milford; Derry C Roopenian; Wayne I Lencer; Richard S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-01       Impact factor: 11.205

Review 5.  Role of chaperones and FcgammaR in immunogenic death.

Authors:  Madhav V Dhodapkar; Kavita M Dhodapkar; Zihai Li
Journal:  Curr Opin Immunol       Date:  2008-06-21       Impact factor: 7.486

6.  Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells.

Authors:  Giang H Pham; Bibiana V Iglesias; Edmund J Gosselin
Journal:  Vaccine       Date:  2014-07-26       Impact factor: 3.641

Review 7.  Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention.

Authors:  T W H Flinsenberg; E B Compeer; J J Boelens; M Boes
Journal:  Clin Exp Immunol       Date:  2011-05-11       Impact factor: 4.330

Review 8.  MHC molecules and microbial antigen processing in phagosomes.

Authors:  Lakshmi Ramachandra; Daimon Simmons; Clifford V Harding
Journal:  Curr Opin Immunol       Date:  2009-02-11       Impact factor: 7.486

9.  B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcgammaRIIb, which are modulated by anti-tumor necrosis factor therapy.

Authors:  Diego Catalán; Octavio Aravena; Francisca Sabugo; Pamela Wurmann; Lilian Soto; Alexis M Kalergis; Miguel Cuchacovich; Juan C Aguillón
Journal:  Arthritis Res Ther       Date:  2010-04-15       Impact factor: 5.156

Review 10.  Bridging innate and adaptive antitumor immunity targeting glycans.

Authors:  Anastas Pashov; Bejatolah Monzavi-Karbassi; Gajendra P S Raghava; Thomas Kieber-Emmons
Journal:  J Biomed Biotechnol       Date:  2010-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.